THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 111 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,059,000 | -14.5% | 210,644 | +20.2% | 0.00% | -25.0% |
| Q1 2021 | $3,578,000 | +213.9% | 175,293 | +173.3% | 0.00% | +300.0% |
| Q4 2020 | $1,140,000 | +20.3% | 64,128 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $948,000 | -44.9% | 64,128 | -15.5% | 0.00% | -75.0% |
| Q2 2018 | $1,721,000 | -41.5% | 75,900 | -37.5% | 0.00% | -42.9% |
| Q1 2018 | $2,944,000 | +42.4% | 121,400 | +112.7% | 0.01% | -12.5% |
| Q3 2016 | $2,068,000 | +57.5% | 57,074 | 0.0% | 0.01% | +60.0% |
| Q2 2016 | $1,313,000 | +4.5% | 57,074 | -28.6% | 0.01% | -16.7% |
| Q1 2016 | $1,256,000 | -4.1% | 79,900 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $1,310,000 | +121.3% | 79,900 | +48.2% | 0.01% | +100.0% |
| Q3 2015 | $592,000 | -46.9% | 53,900 | +54.1% | 0.00% | -40.0% |
| Q2 2014 | $1,115,000 | – | 34,970 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |